Kura Oncology, Inc.KURANASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P33
Within normal range
vs 3Y Ago
-1.4x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
PeriodValue
Q4 2025-9.29%
Q3 2025-12.09%
Q2 2025-15.14%
Q1 2025-198.84%
Q4 202464.68%
Q3 2024-7.02%
Q2 2024-2.65%
Q1 2024-15.75%
Q4 2023-10.84%
Q3 2023-3.84%
Q2 2023-9.11%
Q1 2023-2.88%
Q4 20226.73%
Q3 2022-2.11%
Q2 2022-7.14%
Q1 20220.89%
Q4 20211.87%
Q3 20210.88%
Q2 2021-9.67%
Q1 2021-17.34%
Q4 2020-10.06%
Q3 2020-16.02%
Q2 2020-6.65%
Q1 2020-7.53%
Q4 2019-8.99%
Q3 2019-9.70%
Q2 2019-7.20%
Q1 201913.40%
Q4 2018-7.26%
Q3 2018-1.82%
Q2 2018-0.92%
Q1 2018-35.88%
Q4 2017-15.16%
Q3 2017-19.35%
Q2 2017-3.81%
Q1 2017-2.53%
Q4 2016-6.08%
Q3 2016-3.98%
Q2 2016-0.53%
Q1 2016-2.35%